Registry collecting data on Lipoprotein(a) levels in Argentina
Argentine Registry for the Study of Lipoprotein a
This study is collecting health information from people in Argentina to see how different factors affect their Lipoprotein(a) levels and related heart risks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | School of Medicine. National University of Cuyo Academic / other |
| Locations | 1 site (Mendoza) |
| Trial ID | NCT06297239 on ClinicalTrials.gov |
What this trial studies
The Argentine Registry on Lipoprotein(a) (Lp(a)) is a pioneering observational initiative that systematically gathers geolocation data, demographic information, and various health parameters to explore the associations surrounding Lp(a) levels. This registry includes a wide range of patient characteristics, such as blood pressure, weight, race, diabetes status, smoking habits, menopausal status, and hypothyroidism. It also examines the impact of medication history on Lp(a) profiles, providing valuable insights for clinical and public health considerations. The comprehensive data collection aims to enhance understanding of cardiovascular risks associated with Lp(a).
Who should consider this trial
Good fit: Ideal candidates for this registry are adult patients with validated Lp(a) values.
Not a fit: Patients with associated pathologies that can non-specifically increase Lp(a) values may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved risk assessment and management strategies for cardiovascular diseases related to Lp(a) levels.
How similar studies have performed: While this registry approach is novel in Argentina, similar observational studies have shown success in understanding cardiovascular risk factors globally.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Adult patients with validated Lp(a) values - Exclusion Criteria: Associated pathologies that can increase the Lp(a) value in a non-specific manner -
Where this trial is running
Mendoza
- Universidad Nacional de Cuyo — Mendoza, Argentina (Recruiting)
Study contacts
- Study coordinator: Nicolás F Renna, MD PhD FESC
- Email: nicolasfede@gmail.com
- Phone: +5492615714415
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.